Sun Pharma gets USFDA's nod to market painkillers

view article

Published at: www.hindu.com

New generic oxycodone prvider

April 15, 2009

Analysis by: GLG Expert Contributor

Sun Pharm approval for generic oxycodone represents a new provider in an already crowded field of generic drug manufacturers. This is not a big addition as oxycodone has been avaiable in mutiple configurations for decades. This said, the availability from another source may be helpful as there is a current supply lag for immediate release oxycodone in the US. My concern with an Asian souce lies in the limited ability of US regulatory agencies to oversee these suppliers and their need to relie on their local couterparts. Chinese supply line failures are a perfect example and should be a warning for maintained diligence. 

Aemad AslamPresidentMindPharma

Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone

April 13, 2009

Sun Pharma can greatly benefit from the nationwide shortage of Oxycodone Immediate Release Tablet, by getting approval from the FDA on their own generic. With recent recalls from different manufacturers, and the shortage of a comparable product Morphine Sulphate, the FDA currently estimates that return to normal supply levels of Oxycodone may occur in approximately 2 months, during which time Sun Pharma can capitalize on the shortage by securing longer term contracts with wholesalers.